Japanese structure survey of radiation oncology in 2015.

radiotherapy equipment radiotherapy institution radiotherapy personnel structure survey

Journal

Journal of radiation research
ISSN: 1349-9157
Titre abrégé: J Radiat Res
Pays: England
ID NLM: 0376611

Informations de publication

Date de publication:
17 Mar 2022
Historique:
received: 20 10 2021
revised: 25 11 2021
pubmed: 10 2 2022
medline: 29 3 2022
entrez: 9 2 2022
Statut: ppublish

Résumé

This article describes the ongoing structure of radiation oncology in Japan in terms of equipment, personnel, patient load and geographic distribution to identify and overcome any existing limitations. From May 2016 to August 2018, the Japanese Society for Radiation Oncology conducted a questionnaire based on the Japanese national structure survey of radiation oncology in 2015. Data were analyzed based on the institutional stratification by the annual number of new patients treated with radiotherapy per institution. The estimated annual numbers of new and total (new plus repeat) patients treated with radiation were 225 000 and 271 000, respectively. Additionally, the estimated cancer incidence was 891 445 cases with approximately 25.2% of all newly diagnosed patients being treated with radiation. The types and numbers of treatment devices actually used included linear accelerator (linac; n = 936), Gamma Knife (n = 43), 60Co remote afterloading system (RALS; n = 21), and 192Ir RALS (n = 129). The linac system used dual-energy functions in 754 units, 3D conformal radiotherapy functions in 867, and intensity-modulated radiotherapy (IMRT) functions in 628. There were 899 Japan Radiological Society/Japanese Society for Radiation Oncology-certified radiation oncologists (RO), 1213.9 full-time equivalent (FTE) ROs, 2394.2 FTE radiotherapy technologists (RTT), 295.7 FTE medical physicists, 210.2 FTE radiotherapy quality managers, and 906.1 FTE nurses. The frequency of IMRT use significantly increased during this time. In conclusion, the Japanese structure of radiation oncology has clearly improved in terms of equipment and utility although there was a shortage of personnel in 2015.

Identifiants

pubmed: 35137180
pii: 6523127
doi: 10.1093/jrr/rrab129
pmc: PMC8944304
doi:

Substances chimiques

Iridium Radioisotopes 0
Iridium-192 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

230-246

Subventions

Organisme : Japan Society for the Promotion of Science
ID : JP21K07728

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

J Radiat Res. 2020 Jan 23;61(1):146-160
pubmed: 31825076
Cancer. 2002 Jul 1;95(1):164-71
pubmed: 12115330
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e111-7
pubmed: 21470792
J Radiat Res. 2019 Jan 1;60(1):80-97
pubmed: 30137391
Int J Clin Oncol. 2009 Jun;14(3):237-44
pubmed: 19593616
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1472-6
pubmed: 16029809
J Radiat Res. 2019 Nov 22;60(6):786-802
pubmed: 31665374
Jpn J Clin Oncol. 2005 Sep;35(9):497-506
pubmed: 16120622
Strahlenther Onkol. 2011 Mar;187(3):167-74
pubmed: 21347636
J Radiat Res. 2012 Sep;53(5):710-21
pubmed: 22843366
J Radiat Res. 2020 Sep 8;61(5):799-816
pubmed: 32648574
Int J Clin Oncol. 2013 Oct;18(5):775-83
pubmed: 23053398
Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):144-52
pubmed: 18374515

Auteurs

Hodaka Numasaki (H)

Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita-shi, Osaka, 565-0871, Japan.

Yoshihiro Nakada (Y)

National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.

Yasuo Okuda (Y)

National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.

Hisateru Ohba (H)

National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.

Teruki Teshima (T)

Osaka Heavy Ion Therapy Center, 3-1-10 Otemae, Chuo-ku, Osaka-shi, Osaka, 540-0008, Japan.

Kazuhiko Ogawa (K)

Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka, 565-0871, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH